M3, Inc. (Headquarters: Tokyo, Japan; CEO: Itaru Tanimura; “M3”) has announced the acquisition via M3 USA Corporation, of Michael Allen Company, LLC (Headquarters: Darien, CT, United States; “Michael Allen”), a consulting firm focusing on the pharmaceutical industry. Michael Allen is a pharma-focused consulting firm with therapeutic area expertise in over 100 conditions and many global projects. The company has solid relationships with pharmaceutical companies and methodologies to support clients’ product development according to its process from Phase 1-3 to pre-launch, launch, and inline.
Read the full article: M3 Acquires Michael Allen Company in the U.S. //
Source: https://corporate.m3.com/assets.ctfassets.net/1pwj74siywcy/5Ea6oTGJc626pae4ZDFol1/e1b5191d27f35256f7b0456e8cbab673/20230203_Public_E.pdf